Back to TWO SIGMA ADVISERS, LP TWO SIGMA ADVISERS, LP

REGNREGN
26 quarters

Position history for TWO SIGMA ADVISERS, LPTWO SIGMA ADVISERS, LP's holdings in REGENERON PHARMACEUTICALS

TWO SIGMA ADVISERS, LP holds 604,540 shares of REGN (REGENERON PHARMACEUTICALS), worth $466.6M as of 2025-Q4. The position was decreased (-34.7% shares). REGN represents 0.9% of TWO SIGMA ADVISERS, LP's portfolio.

Current Value

$466.6M

Current Shares

604,540

Total Value Change

+$253.4M

Total Shares Change

+33,539

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Decreased
604,540
-34.7%
$466.6M0.9%$773.94
0
2025-Q3
Decreased
926,200
-1.3%
$520.8M1.0%$560.05
0
2025-Q2
Increased
938,500
+69.5%
$492.7M1.0%$519.56
73
2025-Q1
New
553,800
-
$351.2M0.8%$634.66
61
2024-Q4
Exited
0
-100.0%
$00.0%$698.71
0
2024-Q3
Decreased
900
-10.0%
$946,1160.0%$1,036.94
0
2024-Q2
New
1,000
-
$1.1M0.0%$1,045.23
35
2024-Q1
Exited
0
-100.0%
$00.0%$957.18
0
2023-Q4
Decreased
12,900
-94.7%
$11.3M0.0%$873.45
0
2023-Q3
Decreased
242,900
-18.8%
$199.9M0.5%$818.42
0
2023-Q2
Increased
299,300
+42.7%
$215.1M0.5%$704.51
58
2023-Q1
Increased
209,800
+332.6%
$172.4M0.4%$807.02
59
2022-Q4
Decreased
48,500
-58.1%
$35M0.1%$717.51
0
2022-Q3
Decreased
115,900
-58.5%
$79.8M0.2%$688.00
0
2022-Q2
Decreased
279,000
-43.0%
$164.9M0.5%$594.32
0
2022-Q1
Increased
489,200
+25.9%
$341.7M0.9%$688.56
54
2021-Q4
New
388,500
-
$245.3M0.6%$638.97
60
2020-Q4
Exited
0
-100.0%
$00.0%$475.66
0
2020-Q3
Decreased
52,799
-56.7%
$29.6M0.1%$570.45
0
2020-Q2
Increased
121,899
+145.8%
$76M0.2%$607.50
57
2020-Q1
Increased
49,600
+26.9%
$24.2M0.1%$470.39
35
2019-Q4
Decreased
39,102
-86.2%
$14.7M0.0%$371.64
0
2019-Q3
Increased
283,301
+17.6%
$78.6M0.2%$271.95
41
2019-Q2
Decreased
241,001
-17.4%
$75.4M0.2%$311.27
0
2019-Q1
Decreased
291,601
-48.9%
$119.7M0.3%$408.36
0
2018-Q4
New
571,001
-
$213.3M0.6%$360.62
60

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used